SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that Dr. Robert Greenberg, Chairman, will host one-on-one meetings throughout the day with investors and present at the Rodman & Renshaw 19th Annual Global Investment Conference as follows: Date: Tuesday, September 12, 2017 Time: 1:45 p.m. Ea
Category: Business
Europe Dry Eye Market and Competitive Landscape 2017 – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Europe Dry Eye Market and Competitive Landscape – 2017” report has been added to Research and Markets’ offering. The latest research, Europe Dry Eye Market and Competitive Landscape – 2017, provides comprehensive insights …
Europe Diabetic Retinopathy Market and Competitive Landscape 2017 – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Europe Diabetic Retinopathy Market and Competitive Landscape – 2017” report has been added to Research and Markets’ offering. Europe Diabetic Retinopathy Market and Competitive Landscape – 2017, provides comprehensive insi…
Europe Age-Related Macular Degeneration Market and Competitive Landscape 2017 – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Europe Age-Related Macular Degeneration Market and Competitive Landscape – 2017” report has been added to Research and Markets’ offering. The latest research, Europe Age-Related Macular Degeneration Market and Competitive …
Nightstar Files Registration Statement For Proposed Initial Public Offering
LEXINGTON, Mass. & LONDON–(BUSINESS WIRE)–Nightstar Files Registration Statement For Proposed Initial Public Offering
U.S. Optical Instrument And Lens Market 2017 – Analysis And Forecast to 2025 – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “U.S. Optical Instrument And Lens Market – Analysis And Forecast to 2025” report has been added to Research and Markets’ offering. The report provides an in-depth analysis of the U.S. optical instrument and lens market. It …
Most Physicians Lack Basic Knowledge of Resources to Treat Travelers Experiencing In-Flight Medical Emergencies
PEORIA, Ill.–(BUSINESS WIRE)–42% of physicians reported being asked to volunteer during in-flight medical emergencies but 87% reported little/no knowledge of procedures involved.
Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today announced that the Company has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin the Orion™ Cortical Visual Prosthesis System (Orion) feasibility clinical study. The conditional approval allows two U.S. sites to enroll u
BioTime to Present Data at the Military Health System Research Symposium
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that it will be presenting one podium pres…
Aerie Pharmaceuticals Announces Appointment of Deanne Melloy as Vice President of Marketing and Norbert Lowe as Regional Sales Director
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Deanne Melloy as Vice President of Marketing, reporting to Judith Robertson, Aerie’s Chief Commercial Officer. Aerie also announced the appointment of Norbert Lowe as Regional Sales Director for the
Hubble Contacts Closes Series A-III Financing to Support Global Growth
NEW YORK–(BUSINESS WIRE)–#Contacts–Subscription Contact Lens Brand Hubble Sets Sights on Canada and Beyond Following a $10MM Raise
Global Ophthalmics Partnering 2010-2017: Deal Trends, Players and Financials Analysis Report – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2010-2017: Deal trends, players and financials” report has been added to Research and Markets’ offering. Global Ophthalmics Partnering 2010 to 2017 provides the full collection of Ophthalmics …
Glaukos Announces Participation in Wells Fargo Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
Glaukos Announces Participation in Wells Fargo Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
Iconic Therapeutics Appoints Brandon Smith Chief Operating Officer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Iconic names COO.
Clinical Study Shows That Retinal Imaging May Detect Signs of Alzheimer’s Disease
SACRAMENTO, Calif.–(BUSINESS WIRE)–#Alzheimers–A new study provides the scientific basis for using noninvasive eye imaging to detect the pathological hallmarks of Alzheimer’s disease.
Hollywood Ophthalmologist Dr. Alan Mendelsohn Shares Precautions for Viewing the Eclipse
HOLLYWOOD, Fla.–(BUSINESS WIRE)–#eclipse–In anticipation of the upcoming eclipse on August 21, South Florida Ophthalmologist Dr. Alan Mendelsohn has a warning for the public.
LASIK Surgery Market – Forecasts and Opportunity Assessment by Technavio
LONDON–(BUSINESS WIRE)–#LASIKsurgery–According to the latest market study released by Technavio, the global LASIK surgery market is expected to grow at a CAGR of almost 6% until 2021.
Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration
NEW YORK–(BUSINESS WIRE)–Ophthotech today announced that the pre-specified primary endpoint of mean change in visual acuity at 12 months was not achieved.
Aerie Pharmaceuticals Announces Appointment of Isabel Moredo, PharmD, as Eastern Regional Director of Medical Science Liaisons
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Isabel Moredo, PharmD, as Eastern Regional Director of Medical Science Liaisons, reporting to Welyn Bui, PharmD, Aerie’s National Director of Medical Affairs. Dr. Moredo will be responsible for leadi